The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6,6,6-trifluoro-4-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)hexyl thiophene-2-carboxylate ID: ALA5195172
PubChem CID: 168287590
Max Phase: Preclinical
Molecular Formula: C20H19F3N2O3S
Molecular Weight: 424.44
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(=O)c(C(CCCOC(=O)c2cccs2)CC(F)(F)F)nc2ccccc21
Standard InChI: InChI=1S/C20H19F3N2O3S/c1-25-15-8-3-2-7-14(15)24-17(18(25)26)13(12-20(21,22)23)6-4-10-28-19(27)16-9-5-11-29-16/h2-3,5,7-9,11,13H,4,6,10,12H2,1H3
Standard InChI Key: BAPXJOIJVSSSED-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-3.8671 -0.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1525 -0.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4407 -0.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4407 -1.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1508 -2.1454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8671 -1.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7260 -0.4959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0113 -0.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0113 -1.7337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7260 -2.1462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2967 -2.1462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7260 -2.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2967 -0.4959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2967 0.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4178 -0.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1325 -0.4959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8470 -0.9084 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.4178 0.7418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4178 1.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1325 1.9796 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8470 1.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5617 1.9796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8470 0.7418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6479 2.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4547 2.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8671 2.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3151 1.6442 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.7198 0.2187 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5450 0.2187 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 1 0
4 10 1 0
9 11 2 0
10 12 1 0
8 13 1 0
13 14 1 0
13 15 1 0
15 16 1 0
16 17 1 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
24 22 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 22 1 0
16 28 1 0
16 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 424.44Molecular Weight (Monoisotopic): 424.1068AlogP: 4.67#Rotatable Bonds: 7Polar Surface Area: 61.19Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.75CX LogP: 4.83CX LogD: 4.83Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -1.06
References 1. Jiang X, Wu K, Bai R, Zhang P, Zhang Y.. (2022) Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities., 229 [PMID:34998058 ] [10.1016/j.ejmech.2021.114085 ]